
Imatib A 100mg Capsule
Marketer
Cipla Ltd
Salt Composition
Imatinib mesylate (100mg)
Overview Imatib A 100mg Capsule
Imatib A 100mg capsules treat various cancers, primarily blood cancers like chronic myeloid and acute lymphocytic leukemia, plus gastrointestinal stromal tumors. Its mechanism involves targeting proteins crucial for cancer cell proliferation and metastasis. It's also indicated for dermatofibrosarcoma protuberans (a skin tumor) and aggressive systemic mastocytosis (a bone marrow disorder). Administer this medication with food, consistently at the same time daily for optimal results. Continue treatment as directed by your physician; duration is individualized based on response. Incorrect or excessive usage may lead to severe adverse effects. Therapeutic benefits might not be evident immediately; discontinue only upon your doctor's instruction. Common side effects include swelling, nausea, vomiting, muscle spasms, musculoskeletal discomfort, diarrhea, skin rash, tiredness, and stomach pain. Report unexpected, rapid weight gain to your doctor. Regular blood and liver function tests may be recommended. Avoid driving or tasks requiring concentration if dizziness or blurred vision occurs. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medication isn't recommended during pregnancy or breastfeeding; reliable contraception is essential for both partners during treatment.
Uses of Imatib A 100mg Capsule
Oncological Management
Major Benefits of Imatib A 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume each 100mg Imatib A capsule with food.
Common Side effects of Imatib A 100mg Capsule:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Imatib A 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume each 100mg Imatib A capsule with food.
How Imatib A 100mg Capsule works:
Imatib 100mg capsules are an anti-cancer drug targeting the bcr-abl tyrosine kinase enzyme. This enzyme drives the uncontrolled growth of cancerous cells. By inhibiting this enzyme, Imatib suppresses the proliferation of bcr-abl positive cancer cells and triggers their programmed self-destruction (apoptosis), thus hindering or slowing cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imatib A 100mg Capsules is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Imatib A 100mg capsules is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Imatib A 100mg Capsules while breastfeeding is likely unsafe. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant. Breastfeeding should be discontinued during treatment and for a further 15 days post-treatment.
DrivingUNSAFE
Driving ability may be impaired by the side effects of a 100mg Imatib A capsule.
KidneyCAUTION
For individuals with kidney impairment, the use of Imatib A 100mg Capsules requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, Imatib A 100mg capsules require careful administration. Dosage modification of Imatib A 100mg capsules may be necessary. Physician consultation is advised.
What if you forget to take Imatib A 100mg Capsule :
Omit any missed Imatib A 100mg Capsule dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Imatib A 100mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Benzanilide Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
